Bristol-Myers Squibb Company v. Teva Pharmaceuticals USA Inc.
1:10-cv-00264
Overview
Parties
Defendant
Teva Pharmaceuticals USA Inc. Operating Company
Represented By
0 Attorneys ListedBristol-Myers Squibb Company NPE (Individual / Inventor)
Represented By
1 Attorneys ListedDLA Piper LLP
1201 N. Market Street, Suite 2100, Wilmington, DE 19801
Novartis Corporation Operating Company
Represented By
1 Attorneys ListedDLA Piper LLP
1201 N. Market Street, Suite 2100, Wilmington, DE 19801
Plaintiff
Novartis Pharma AG Operating Company
Represented By
1 Attorneys ListedDLA Piper LLP
1201 N. Market Street, Suite 2100, Wilmington, DE 19801
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 3 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | Asserted Patent | View Official Patent → |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
Bristol-Myers Squibb Company v. Cipla USA, Inc.
Bristol-Myers Squibb Company v. Mylan Pharmaceuticals, Inc.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US5849911
Antivirally active heterocyclic azahexane derivatives
|
Filed: 1997-04-09
Issued: 1998-12-15
|
Expired (Term Ended)
Expires: 2003-08-31
|
|
|
US6087383
Bisulfate salt of HIV protease inhibitor
|
Filed: 1998-12-21
Issued: 2000-07-11
|
Expired (Term Ended)
Expires: 2018-12-21
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).